The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets-Reference-Cited by-同舟云学术

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets

Published:2020-04-06 Issue: Volume: Page:
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Altamura Fernando¹^ORCID,Rajesh Rishi¹^ORCID,Catta-Preta Carolina M. C.²^ORCID,Moretti Nilmar S.³^ORCID,Cestari Igor¹^ORCID

Affiliation:

1. Institute of Parasitology; McGill University; Ste Anne de Bellevue Quebec Canada

2. Structural Genomics Consortium; Universidade Estadual de Campinas-UNICAMP; Campinas SP Brazil

3. Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina; Universidade Federal de São Paulo; São Paulo SP Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de São Paulo

Natural Sciences and Engineering Research Council of Canada

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21664/fullpdf

Reference193 articles.

1. A genomic scale map of genetic diversity in Trypanosoma cruzi;Ackermann;BMC Genomics,2012

2. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo;Agusti;Glycobiology,2004

3. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis;Alcantara;International Journal for Parasitology: Drugs and Drug Resistance,2018

4. High-throughput decoding of antitrypanosomal drug efficacy and resistance;Alsford;Nature,2012

5. High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome;Alsford;Genome Research,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis;Pharmaceutics;2024-02-04

2. Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis;Biomedicines;2024-01-17

3. The role of tryptophan derivatives as anti-kinetoplastid agents;Heliyon;2024-01

4. Antileishmanial and Antitrypanosomes Drugs for the Current Century;Microorganisms;2023-12-26

5. Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?;Medicinal Research Reviews;2023-12-24